Goldman Sachs’s Aurora Cannabis ACB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-50,000
Closed -$4.52M 6193
2021
Q2
$4.52M Buy
+50,000
New +$4.33M ﹤0.01% 3426
2019
Q2
Sell
-4,167
Closed -$4.53M 5097
2019
Q1
$4.53M Buy
+4,167
New +$3.73M ﹤0.01% 3045

Other funds holding ACB

Goldman Sachs's ACB Position: Q1 2026 in Review

Goldman Sachs increased its Aurora Cannabis (ACB) stake by 6.4% in Q1 2026, buying an estimated $238K and bringing the position to 1,056,218 shares worth $3.45M. The position accounts for ﹤0.01% of the portfolio, ranked #4048.

Goldman Sachs first reported a position in ACB in Q4 2018 and has held it in 29 quarters since. The position peaked at $10.3M in Q3 2025. 155 funds tracked by Wall St. Rank hold ACB as of Q1 2026.

  • Goldman Sachs held 1,056,218 shares of Aurora Cannabis worth $3.45M as of Q1 2026.
  • Goldman Sachs bought 63,087 Aurora Cannabis shares in Q1 2026, an estimated $238K.
  • Aurora Cannabis made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #4048 holding.
  • Goldman Sachs first reported a position in Aurora Cannabis in Q4 2018 and has held it in 29 quarters since.
  • Goldman Sachs's Aurora Cannabis position peaked at $10.3M in Q3 2025.
  • 155 funds tracked by Wall St. Rank held Aurora Cannabis as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.